中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu

2022 No.1
Theme Issue: Big Data and Artificial Intelligence Enable a New Era of Digital Diagnosis and Treatment in Liver Surgery
Executive Chief Editor: LIU Jingfeng  
Mengchao Hepatobiliary Hospital of Fujian Medical University
Cover Content

 Previous Issue | Next Issue 

Display Method:
Editorial
Application status and prospect of artificial intelligence in surgical treatment of primary liver cancer
Hongzhi LIU, Jingfeng LIU
2022, 38(1): 10-14. DOI: 10.3969/j.issn.1001-5256.2022.01.001
Abstract(1148) HTML (292) PDF (1982KB)(188) Cited By (8)
Abstract:
Primary liver cancer is one of the most common and fatal malignant tumors, and surgical treatment is the most important radical treatment method, but there is still a high postoperative recurrence rate and poor prognosis. In recent years, emerging techniques represented by artificial intelligence ha...
Discussions by Experts
Application of bioinformatics in predicting the risk of hepatocellular carcinoma
Guoxu FANG, Qinghua ZHANG, Yongying HUANG, Jianmin WANG, Jingfeng LIU
2022, 38(1): 15-19. DOI: 10.3969/j.issn.1001-5256.2022.01.002
Abstract(1021) HTML (294) PDF (1986KB)(154) Cited By (4)
Abstract:
Bioinformatics is an interdisciplinary science that combines the tools of mathematics, computer science, and biology to clarify and explore the biological implications of large amounts of biological data. With the continuous development of genome sequencing technology, a large number of biological d...
Application and prospect of deep learning in primary liver cancer-related diagnostic model
Qinghua ZHANG, Haitao LI, Guoxu FANG, Pengfei GUO, Jingfeng LIU
2022, 38(1): 20-25. DOI: 10.3969/j.issn.1001-5256.2022.01.003
Abstract(1092) HTML (464) PDF (1997KB)(188) Cited By (6)
Abstract:
Deep learning is a process in which machine learning obtains new knowledge and skills by simulating the learning behavior of human brain through massive data training and analysis. With the development of medical technology, a large amount of data has been accumulated in the medical field, and the r...
Application of artificial intelligence in the diagnosis and treatment of primary liver cancer
Chihua FANG, Wei CAI
2022, 38(1): 26-29. DOI: 10.3969/j.issn.1001-5256.2022.01.004
Abstract(1272) HTML (209) PDF (1971KB)(168) Cited By (4)
Abstract:
In the era of medical big data, artificial intelligence is increasingly widely used in medicine. Efficient management and information mining of massive medical data can obtain useful information on disease development, progression, survival, and prognosis. In recent years, some achievements have bee...
Application of artificial intelligence in liver transplantation
Zhixing LIANG, Linsen YE, Yang YANG
2022, 38(1): 30-34. DOI: 10.3969/j.issn.1001-5256.2022.01.005
Abstract(942) HTML (286) PDF (1981KB)(125) Cited By (1)
Abstract:
With the advent of the era of 5G and big data, complex medical data with multiple dimensions and a large sample size bring both opportunities and challenges for clinical medicine in the new era. Compared with conventional methods, artificial intelligence can detect the hidden patterns within large d...
Guidelines
Guidelines on the diagnosis and management of primary biliary cholangitis (2021)
Chinese Society of Hepatology
2022, 38(1): 35-41. DOI: 10.3760/cma.j.cn112138-20211112-00794
Abstract(3239) HTML (1370) PDF (2416KB)(1313) Cited By (95)
Abstract:
In 2015, the Chinese Society of Hepatology and Chinese Society of Gastroenterology issued the consensus on the diagnosis and management of primary biliary cholangitis (PBC). In the past years, more clinical studies have been reported in the field of PBC. To provide guidance to the clinical diagnosis...
Guidelines on the diagnosis and management of autoimmune hepatitis (2021)
Chinese Society of Hepatology, Chinese Medical Association
2022, 38(1): 42-49. DOI: 10.3760/cma.j.cn112138-20211112-00796
Abstract(6837) HTML (628) PDF (2917KB)(1943) Cited By (119)
Abstract:
Autoimmune hepatitis (AIH) is characterized by elevated serum aminotransferase and immunoglobulin G levels, seropositive results for autoantibodies and moderate to severe interface hepatitis in histologic findings. It will be most helpful in improving survival and life quality, if patients are diagn...
Guidelines on the diagnosis and management of primary sclerosing cholangitis (2021)
Chinese Society of Hepatology, Chinese Medical Association
2022, 38(1): 50-61. DOI: 10.3760/cma.j.cn112138-20211109-00786
Abstract(1960) HTML (264) PDF (2577KB)(681) Cited By (40)
Abstract:
In 2015, the first Chinese consensus on the diagnosis and management of primary sclerosing cholangitis was issued. In the past years, more data have emerged from the literature. Herein, the Autoimmune Liver Disease Group of the Chinese Society of Hepatology organized an expert group to review the ev...
Guideline on the management of cholestasis liver diseases(2021)
Chinese Society of Hepatology, Chinese Medical Association
2022, 38(1): 62-69. DOI: 10.3760/cma.j.cn112138-20211112-00795
Abstract(3314) HTML (1794) PDF (4200KB)(1508) Cited By (48)
Abstract:
In 2015, the Chinese Society of Hepatology and Chinese Society of Gastroenterology issued the consensus on the diagnosis and management of cholestatic liver diseases. In the past years, more data have emerged from clinical practice. Herein, the Autoimmune Liver Disease Group of the Chinese Society o...
Interventional expert consensus on integrated traditional Chinese and Western medicine for the diagnosis and treatment of hepatocellular carcinoma(trial editionⅠ)
2019 Expert Committee on Clinical Coordination of Traditional Chinese and Western Medicine for Liver Cancer
2022, 38(1): 70-77. DOI: 10.3969/j.issn.1001-5256.2022.01.010
Abstract(1915) HTML (290) PDF (3410KB)(480) Cited By (34)
Abstract:
This consensus is compiled by the experts of hepatocellular carcinoma(HCC) project team, which is under the "major and difficult diseases-the clinical cooperation project of traditional Chinese medicine and Western medicine" of the State Administration of Traditional Chinese Medicine of China. This ...
An excerpt of APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients (2021)
Shan REN, Sujun ZHENG
2022, 38(1): 78-80. DOI: 10.3969/j.issn.1001-5256.2022.01.011
Abstract(857) HTML (317) PDF (1949KB)(264) Cited By (4)
Abstract:
Original Articles_Viral Hepatitis
Value of serum free triiodothyronine level in predicting the prognosis of patients with HBV-related acute-on-chronic liver failure
Jian ZHANG, Yu CHEN, Zhongping DUAN
2022, 38(1): 81-85. DOI: 10.3969/j.issn.1001-5256.2022.01.012
Abstract(801) HTML (120) PDF (2175KB)(89) Cited By (12)
Abstract:
Objective To investigate the value of serum free triiodothyronine (FT3) level in predicting the 90-day prognosis of patients with hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF). Methods Related clinical data were collected from 122 patients with HBV-ACLF who were hospitalized ...
Prognosis of acute-on-chronic liver failure caused by hepatitis recurrence after withdrawal of nucleos(t)ide analogues in chronic hepatitis B patients with different HBeAg status
Jiacong SHEN, Xiaopeng LI, Xiaoyu CHENG, Yuanmei CHE, Wan LEI, Guanlin ZHOU, Lunli ZHANG
2022, 38(1): 86-90. DOI: 10.3969/j.issn.1001-5256.2022.01.013
Abstract(894) HTML (119) PDF (1984KB)(71) Cited By (6)
Abstract:
Objective To investigate the difference in the prognosis of hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) caused by hepatitis recurrence after withdrawal of nucleos(t)ide analogues (NUC) and possible causes in HBeAg-positive versus HBeAg-negative chronic hepatitis B (CHB) patie...
Clinical effect of direct-acting antiviral agents in treatment of chronic hepatitis C patients with thrombocytopenia
Tao WANG, Fenghui LI, Jing LIANG, Huiling XIANG, Fang LIU, Hongmin LYU, Baoxin QIAN, Jiajun TIAN
2022, 38(1): 91-96. DOI: 10.3969/j.issn.1001-5256.2022.01.014
Abstract(826) HTML (160) PDF (2173KB)(66) Cited By (3)
Abstract:
Objective To investigate the clinical effect of direct-acting antiviral agent (DAA) in the treatment of chronic hepatitis C (CHC) patients with thrombocytopenia and its effect on platelet count (PLT). Methods A retrospective analysis was performed for 83 CHC patients with thrombocytopenia (PLT < ...
Original Articles_Liver Fibrosis and Liver Cirrhosis
Diagnostic value of transient elastography in the staging of hepatic fibrosis in patients with autoimmune liver disease: A Meta-analysis
Zhiran YANG, Linheng WANG, Yuan LI, Fusheng LIU, Yu WANG, Jianfang WANG, Runhua CHEN
2022, 38(1): 97-103. DOI: 10.3969/j.issn.1001-5256.2022.01.015
Abstract(961) HTML (479) PDF (5357KB)(89) Cited By (12)
Abstract:
Objective To investigate the value of transient elastography (TE) in the staging of hepatic fibrosis in patients with autoimmune liver disease (ALD). Methods PubMed, Embase, the Cochrane Library, CNKI, Wanfang Data, and VIP databases were searched for English and Chinese articles on TE in the stagin...
Value of five noninvasive diagnostic methods for liver cirrhosis in diagnosis of traditional Chinese medicine syndrome types in patients with compensated hepatitis B cirrhosis
Zhongjie YU, Wenxia ZHAO, Leixin FENG, Hanxiao WANG, Jianpeng LIU
2022, 38(1): 104-109. DOI: 10.3969/j.issn.1001-5256.2022.01.016
Abstract(801) HTML (145) PDF (2578KB)(60) Cited By (19)
Abstract:
Objective To investigate the association of five noninvasive diagnostic methods for liver cirrhosis, i.e., liver stiffness measurement (LSM) on FibroScan, aspartate aminotransferase-to-platelet ratio index (APRI), fibrosis-4 (FIB-4), gamma-glutamyl transpeptidase-to-platelet ratio (GPR), and red blo...
Original Articles_Liver Neoplasms
Establishment of a nomogram for survival rate after liver resection for primary small hepatocellular carcinoma based on SEER data and external validation
Haoyou TANG, Sheng LIU, Xin ZENG, Xiaobin HUANG, Yang YANG, Dawei DENG, Jianshui LI
2022, 38(1): 110-116. DOI: 10.3969/j.issn.1001-5256.2022.01.017
Abstract(917) HTML (318) PDF (4273KB)(71) Cited By (6)
Abstract:
Objective To establish a nomogram for overall survival rate after liver resection for primary small hepatocellular carcinoma based on SEER data and external validation of Chinese data. Methods The data of 1809 patients, registered in National Cancer Institute SEER database in 2004-2015, who underwen...
Expression of interleukin-33 in hepatocellular carcinoma patients and its role in regulating CD8+ T cell function
Haipeng WANG, Yi LIU, Donghui LI, Guanghui SHEN
2022, 38(1): 117-123. DOI: 10.3969/j.issn.1001-5256.2022.01.018
Abstract(658) HTML (151) PDF (3969KB)(62) Cited By (2)
Abstract:
Objective To investigate the change in interleukin-33 (IL-33) in the peripheral blood of hepatocellular carcinoma (HCC) patients and the role and potential mechanism of IL-33 in regulating CD8+ T cell function in HCC patients. Methods A total of 44 HCC patients who attended Shaanxi Provincial People...
Original Articles_Other Liver Diseases
Effect of ideal cardiovascular health metrics on the incidence rate of nonalcoholic fatty liver disease
Dongna ZHAO, Qian LIU, Huijie LIANG, Haozhe CUI, Lingqun MENG, Huiliang E, Liying CAO
2022, 38(1): 124-128. DOI: 10.3969/j.issn.1001-5256.2022.01.019
Abstract(625) HTML (134) PDF (1983KB)(44) Cited By (6)
Abstract:
Objective To investigate the association of ideal cardiovascular health metrics with the incidence rate of nonalcoholic fatty liver disease (NAFLD), and to provide a basis for the prevention and control of NAFLD. Methods A prospective cohort study was conducted for the data of 50 511 employees of Ka...
Value of lipid accumulation product and visceral fat index in predicting nonalcoholic fatty liver disease
Shaojie DUAN, Zunjing LIU, Jialiang CHEN, Shukun YAO
2022, 38(1): 129-134. DOI: 10.3969/j.issn.1001-5256.2022.01.020
Abstract(1116) HTML (159) PDF (2973KB)(108) Cited By (19)
Abstract:
Objective To investigate the association of lipid accumulation product (LAP) and visceral fat index (VAI) with nonalcoholic fatty liver disease (NAFLD) and the value of LAP and VAI in predicting the risk of NAFLD. Methods A total of 708 subjects who underwent physical examination in China-Japan Frie...
Efficacy of artificial liver support system in treatment of acute-on-chronic liver failure: A network Meta-analysis
Liangliang GAN, Jinzhou ZHANG, Xiandong WANG, Caihong FU, Jia SU, Xuemei TANG
2022, 38(1): 135-140. DOI: 10.3969/j.issn.1001-5256.2022.01.021
Abstract(1439) HTML (246) PDF (4674KB)(116) Cited By (18)
Abstract:
Objective To systematically review the efficacy of different artificial liver support systems in the treatment of acute-on-chronic liver failure (ACLF) using a network Meta-analysis. Methods PubMed, Embase, the Cochrane library, Clinical Trial, CNKI, SinoMed, and Wanfang Data were searched for rando...
Diagnostic values of integrated evidence chain, Roussel Uclaf Causality Assessment Method, and Structured Expert Opinion Process method for drug-induced liver injury
Tingting HE, Qingsheng LIANG, Liping WANG, Longxin LIANG, Xiaohan LI, Yanfei CUI, Jing JING, Zhaofang BAI, Man GONG, Ruilin WANG
2022, 38(1): 141-147. DOI: 10.3969/j.issn.1001-5256.2022.01.022
Abstract(832) HTML (164) PDF (2269KB)(72) Cited By (9)
Abstract:
Objective To investigate the clinical applicability and different characteristics of three commonly used diagnostic methods for drug-induced liver injury from the two aspects of liver injury induced by Western medicine and liver injury induced by traditional Chinese medicine. Methods A prospective c...
Clinical features and autoantibody characteristics of patients with drug-induced liver injury: An analysis of 419 cases
Fengxin CHEN, Zhan ZENG, Fangfang SUN, Leiping HU, Yao LU, Lu ZHANG, Minghui LI, XIE Yao
2022, 38(1): 148-153. DOI: 10.3969/j.issn.1001-5256.2022.01.023
Abstract(883) HTML (142) PDF (2079KB)(88) Cited By (7)
Abstract:
Objective To investigate the clinical features and autoantibody characteristics of patients with drug-induced liver injury (DILI). Methods A retrospective analysis was performed for the patients with abnormal liver function who were admitted to Beijing Ditan Hospital, Capital Medical University, fro...
Clinical and pathological features of progressive familial intrahepatic cholestasis type 3
Yuhang WENG, Qingfang XIONG, Duxian LIU, Xulei ZHANG, Yongfeng YANG
2022, 38(1): 154-159. DOI: 10.3969/j.issn.1001-5256.2022.01.024
Abstract(1220) HTML (492) PDF (2621KB)(114) Cited By (3)
Abstract:
Objective To investigate the clinical and pathological features of progressive familial intrahepatic cholestasis type 3 (PFIC3). Methods A retrospective analysis was performed for 1326 patients with unexplained liver disease who attended Nanjing Second Hospital from January 2017 to December 2019, am...
Original Articles_Biliary Diseases
Application of indocyanine green cholangiography in accurate identification of the common bile duct in laparoscopic cholecystectomy
Jun YANG, Hao JIN
2022, 38(1): 160-163. DOI: 10.3969/j.issn.1001-5256.2022.01.025
Abstract(983) HTML (547) PDF (2140KB)(79) Cited By (17)
Abstract:
Objective To investigate the application of intraoperative indocyanine green (ICG) cholangiography in the accurate identification of the common bile duct since common bile duct injury is a common complication of laparoscopic cholecystectomy (LC), and to reduce the incidence rate of common bile duct ...
Case Reports
A case of severe allergic hepatitis caused by eosinophilia
Jie SU, Jingyu WANG, Xing HUANG, Yu PAN, Yue QI, Rui HUA
2022, 38(1): 164-166. DOI: 10.3969/j.issn.1001-5256.2022.01.026
Abstract(947) HTML (159) PDF (2349KB)(82)
Abstract:
A compound heterozygous mutation in the ATP7B gene with acute fatty liver of pregnancy: A case report
Dan YANG, Cuiwei ZHANG, Mingming DENG
2022, 38(1): 167-169. DOI: 10.3969/j.issn.1001-5256.2022.01.027
Abstract(570) HTML (227) PDF (3181KB)(48)
Abstract:
IgG4-related autoimmune hepatitis with subacute liver failure as the initial manifestation: A case report
Li JIANG, Huimin LIU, Qing MAO
2022, 38(1): 170-173. DOI: 10.3969/j.issn.1001-5256.2022.01.028
Abstract(1076) HTML (233) PDF (3941KB)(59) Cited By (5)
Abstract:
Follicular dendritic cell sarcoma of the liver: A case report
Chenguang LI, Jiyao JIA, Luanbiao SUN, Shuohui GAO
2022, 38(1): 174-176. DOI: 10.3969/j.issn.1001-5256.2022.01.029
Abstract(1111) HTML (319) PDF (2854KB)(52) Cited By (1)
Abstract:
Endoscopic treatment of gastroesophageal varices complicated by posterior reversible encephalopathy syndrome: A case report
Tingting YU, Shanshan JIANG, Mengran ZHU, Yun BAI
2022, 38(1): 177-179. DOI: 10.3969/j.issn.1001-5256.2022.01.030
Abstract(466) HTML (84) PDF (3069KB)(38) Cited By (1)
Abstract:
Reviews
Research advances in interferon-stimulated genes in treatment of hepatitis B virus infection
Yunwen LIAN, Xingrong ZHENG, Hewei WU, Zhiliang GAO, Xiyao CHEN, Chan XIE
2022, 38(1): 180-186. DOI: 10.3969/j.issn.1001-5256.2022.01.031
Abstract(1083) HTML (784) PDF (3342KB)(264) Cited By (8)
Abstract:
Hepatitis B virus (HBV) infection is closely associated with the adverse events such as liver cirrhosis, liver cancer, and liver failure and remains a serious threat to human health. Pegylated interferon is an indispensable drug for the treatment of chronic hepatitis B (CHB), and interferon-stimulat...
Association between intrahepatic bile duct alterations and liver fibrosis
Wenzheng YOU, Wanlei REN, Shiying XUAN, Doudou HU
2022, 38(1): 187-190. DOI: 10.3969/j.issn.1001-5256.2022.01.032
Abstract(886) HTML (220) PDF (1972KB)(103) Cited By (7)
Abstract:
Liver cirrhosis is a liver disease caused by various factors and is characterized by diffuse fibrous hyperplasia, lobular structural damage, and pseudolobule formation. Bile duct proliferation has been observed in a variety of animal models of liver cirrhosis and patients with liver cirrhosis caused...
Current status of the pathogenesis, diagnosis, and treatment of sarcopenia in patients with liver cirrhosis
Yuyi LIU, Dongfeng CHEN, Qixian YAN
2022, 38(1): 191-195. DOI: 10.3969/j.issn.1001-5256.2022.01.033
Abstract(904) HTML (187) PDF (1987KB)(134) Cited By (17)
Abstract:
Sarcopenia is a common complication in patients with liver cirrhosis, with an incidence rate of up to 40%-70%, which increases the incidence rate of complications in patients with liver cirrhosis and seriously affects patients' quality of life and survival time. Sarcopenia in liver cirrhosis has a c...
Research advances in nonalcoholic fatty liver disease-related hepatocellular carcinoma
Xuelian GU, Junfeng LI, Xiaorong MAO
2022, 38(1): 196-200. DOI: 10.3969/j.issn.1001-5256.2022.01.034
Abstract(1110) HTML (416) PDF (2546KB)(207) Cited By (3)
Abstract:
The incidence rate of nonalcoholic fatty liver disease-related hepatocellular carcinoma (NAFLD-HCC) tends to increase worldwide, while its pathogenesis remains unclear. With reference to the literature in recent years, this article summarizes the role of adipose tissue inflammation, oxidative stress...
Research advances in in vitro models for nonalcoholic fatty liver disease
Xiaochen LU, Hongmei HAN
2022, 38(1): 201-205. DOI: 10.3969/j.issn.1001-5256.2022.01.035
Abstract(1283) HTML (614) PDF (2000KB)(235) Cited By (6)
Abstract:
The incidence rate of nonalcoholic fatty liver disease (NAFLD) is increasing year by year, with limited treatment methods, and its pathogenesis is a research hotspot at present. In order to better clarify its pathogenesis, it is urgent to develop advanced, safe, and effective in vitro or in vivo mod...
Research advances in the protective effect of sulforaphane against liver injury and related mechanisms
Xinyu MA, Tingting DUAN, Jingya XU, Jiahe ZHAO, Chunlei ZHANG, Baolong LI
2022, 38(1): 206-209. DOI: 10.3969/j.issn.1001-5256.2022.01.036
Abstract(738) HTML (226) PDF (1983KB)(37) Cited By (4)
Abstract:
Sulforaphane is a phytochemical with a variety of biological activities that exists widely in Cruciferae plants. This article summarizes the recent experimental studies of sulforaphane in the treatment of various types of liver injury in China and globally and reviews the role and mechanism of sulfo...
Research advances in targeting autophagy to alleviate hepatic ischemia-reperfusion injury
Zhen LI, Ke WANG, Kaiqiang WANG, Kexian YU
2022, 38(1): 210-214. DOI: 10.3969/j.issn.1001-5256.2022.01.037
Abstract(649) HTML (183) PDF (3164KB)(45) Cited By (8)
Abstract:
Hepatic ischemia-reperfusion injury (HIRI) is a common clinical problem after hepatectomy and liver transplantation and is the main cause of liver dysfunction and liver failure after transplantation. In recent years, autophagy-mediated pathways have become a research hotspot in alleviating HIRI. Aut...
Current status of research on nutritional support in end-stage liver disease
Honglin MA, Jing YANG, Qiu JIN, Run LUO, Jiao LENG, Xia WANG
2022, 38(1): 215-219. DOI: 10.3969/j.issn.1001-5256.2022.01.038
Abstract(758) HTML (172) PDF (1987KB)(170) Cited By (11)
Abstract:
There is a high prevalence rate of malnutrition in patients with end-stage liver disease, which often promotes disease progression and has a negative impact on the prognosis of patients. This article briefly describes the etiology of malnutrition in end-stage liver disease and introduces the researc...
Research advances in adverse liver reactions caused by immune checkpoint inhibitors
Yu WANG, Zhaoying LI, Shuang LI, Chenghai LIU
2022, 38(1): 220-223. DOI: 10.3969/j.issn.1001-5256.2022.01.039
Abstract(1553) HTML (270) PDF (1985KB)(259) Cited By (8)
Abstract:
Immune checkpoint inhibitors can enhance the anti-tumor effect of T cells by blocking the negative regulatory signal of T cells, and meanwhile, they may also cause the imbalance of immune tolerance or normal immune hyperfunction, thus leading to immune hepatitis. This article mainly reviews the ther...
Research advances in the mechanism of action of TRPV4 ion channel protein in liver diseases
Laying ZHANG, Mingkai CHEN
2022, 38(1): 224-227. DOI: 10.3969/j.issn.1001-5256.2022.01.040
Abstract(819) HTML (283) PDF (1981KB)(37) Cited By (1)
Abstract:
As a member of the transient receptor potential ion channel family, transient receptor potential vanilloid 4 (TRPV4) is a non-selective cation channel and is widely distributed in a variety of tissues and organs. In recent years, more and more studies have shown that TRPV4 channel proteins are close...
Nutritional assessment and treatment management of infantile cholestatic liver disease
Lina DU, Lulu XIA, Jie YAN, Ziyun GUO, Yan YANG
2022, 38(1): 228-232. DOI: 10.3969/j.issn.1001-5256.2022.01.041
Abstract(775) HTML (167) PDF (1989KB)(64) Cited By (5)
Abstract:
Children with infantile cholestatic liver disease are often accompanied by malnutrition, which in turn can affect its progression and prognosis. There are many factors causing malnutrition and various methods for malnutrition assessment, but there is still a lack of uniform standard for nutritional ...
Research advances in the molecular diagnosis of spontaneous bacterial peritonitis
Haoxin WU, Zhongjie HU
2022, 38(1): 233-235. DOI: 10.3969/j.issn.1001-5256.2022.01.042
Abstract(601) HTML (161) PDF (1961KB)(75) Cited By (2)
Abstract:
Spontaneous bacterial peritonitis (SBP) is the most common type of infection in end-stage liver disease, and the diagnosis and treatment of SBP are facing great difficulties and challenges. In recent years, great achievements have been made in molecular diagnostic techniques, but they have not been ...
Research advances in the molecular mechanism of long non-coding RNA in invasion and metastasis of pancreatic cancer
Jian XU, Yanni PAN, Xinyuan LIU, Jianxin JIANG
2022, 38(1): 236-240. DOI: 10.3969/j.issn.1001-5256.2022.01.043
Abstract(790) HTML (351) PDF (2998KB)(68) Cited By (3)
Abstract:
As a highly malignant gastrointestinal tumor, pancreatic cancer is highly invasive and metastatic, which leads to the low overall survival rate of patients with pancreatic cancer. Studies have shown that long non-coding RNA (lncRNA) is involved in the development, progression, invasion, and metastas...
Thanks
Current reviewers
2022, 38(1): 61-61. DOI: 10.3969/j.issn.1001-5256.zhixie
Abstract(616) HTML (171) PDF (971KB)(38)
Abstract:

YU Lecheng Wan Hong WANG Aiping WANG Lei KONG Yuanyuan CHENG Yu ZHU Ying ZHU Xuan QIAO Shixing REN Yongqiang LIU Jinchun LIU Hui LIU Hailin LIU Binbin LIU Mei LIU Yinkun LIU Hongling XU Hongmei SUN Changyu SUN Mingyu SU Zhijun DU Xilin LI Guangkuo LI Hongyu LI Zhenfang XIAO Yonghong XIAO Lin WU Hesh...
    

The first journal specializing in hepatobiliary and pancreatic diseases in China

Supervisor：Ministry of Education of the People's Republic of China

Sponsor：Jilin University

Academic Support: Chinese Society of Hepatology，Chinese Medical Association

Address: 461 Xinjiang Road, Changchun

Submit：0431-88782044

Peer review：0431-88783542

Email：lcgdb@vip.163.com

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

YesterdayIP[2433]YesterdayPV[3993]TodayIP[1409]TodayPV[2108]Online[119]

Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd